1. Home
  2. ARWR

as 06-13-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Founded: N/A Country:
United States
United States
Employees: N/A City: PASADENA
Market Cap: 3.1B IPO Year: 1993
Target Price: $47.89 AVG Volume (30 days): 1.0M
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.24 EPS Growth: N/A
52 Week Low/High: $20.67 - $39.83 Next Earning Date: 08-05-2024
Revenue: $35,473,000 Revenue Growth: -87.00%
Revenue Growth (this year): -56.61% Revenue Growth (next year): 41.78%

ARWR Daily Stock ML Predictions

Stock Insider Trading Activity of Arrowhead Pharmaceuticals Inc. (ARWR)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Vakiener Victoria ARWR Director May 2 '24 Sell $23.31 1,799 $41,934.69 30,205 SEC Form 4
Hamilton James C ARWR Chief Discovery/Trans Medicine Apr 1 '24 Sell $28.03 6,000 $168,180.00 204,851 SEC Form 4
Lu Hongbo ARWR Director Mar 18 '24 Buy $27.49 1,000 $27,490.00 31,680 SEC Form 4
Lu Hongbo ARWR Director Mar 18 '24 Buy $28.00 1,000 $28,000.00 32,680 SEC Form 4
Lu Hongbo ARWR Director Mar 18 '24 Buy $27.50 1,000 $27,500.00 33,680 SEC Form 4
Anzalone Christopher Richard ARWR Chief Executive Officer Jan 31 '24 Sell $32.16 37,769 $1,214,651.04 3,734,778 SEC Form 4
Anzalone Christopher Richard ARWR Chief Executive Officer Jan 31 '24 Sell $32.71 19,730 $645,368.30 3,715,048 SEC Form 4
Hamilton James C ARWR Chief Discovery/Trans Medicine Jan 12 '24 Sell $36.47 4,238 $154,559.86 214,553 SEC Form 4
Hamilton James C ARWR Chief Discovery/Trans Medicine Jan 12 '24 Sell $37.37 3,702 $138,343.74 210,851 SEC Form 4
Waddill William D. ARWR Director Jan 11 '24 Sell $37.81 2,634 $99,591.54 49,170 SEC Form 4
Waddill William D. ARWR Director Jan 11 '24 Sell $38.59 1,300 $50,167.00 47,870 SEC Form 4
Ferrari Mauro ARWR Director Jan 11 '24 Sell $37.80 2,147 $81,156.60 61,778 SEC Form 4
Ferrari Mauro ARWR Director Jan 11 '24 Sell $38.63 1,000 $38,630.00 60,778 SEC Form 4
Vakiener Victoria ARWR Director Jan 11 '24 Sell $37.87 3,620 $137,089.40 33,101 SEC Form 4
Vakiener Victoria ARWR Director Jan 11 '24 Sell $38.84 1,100 $42,724.00 32,001 SEC Form 4
GIVEN DOUGLAS B ARWR Director Jan 11 '24 Sell $37.76 1,811 $68,383.36 130,811 SEC Form 4
GIVEN DOUGLAS B ARWR Director Jan 11 '24 Sell $38.55 1,100 $42,405.00 129,711 SEC Form 4
Oliver Tracie ARWR Chief Commercial Officer Jan 4 '24 Sell $33.89 74 $2,507.86 136,501 SEC Form 4
San Martin Javier ARWR Chief Medical Officer Jan 4 '24 Sell $34.11 800 $27,288.00 206,000 SEC Form 4
San Martin Javier ARWR Chief Medical Officer Jan 4 '24 Sell $35.03 3,100 $108,593.00 202,900 SEC Form 4
San Martin Javier ARWR Chief Medical Officer Jan 4 '24 Sell $35.64 4,403 $156,922.92 198,497 SEC Form 4
O'Brien Patrick ARWR COO and General Counsel Jan 3 '24 Sell $31.83 3,849 $122,513.67 408,726 SEC Form 4
O'Brien Patrick ARWR COO and General Counsel Jan 3 '24 Sell $32.52 2,800 $91,056.00 405,926 SEC Form 4
O'Brien Patrick ARWR COO and General Counsel Jan 3 '24 Sell $33.41 400 $13,364.00 405,526 SEC Form 4
O'Brien Patrick ARWR COO and General Counsel Jan 3 '24 Sell $32.65 1,700 $55,505.00 403,826 SEC Form 4

Share on Social Networks: